These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16101159

  • 21. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
    Wigington DP, Urben CM, Strugnell SA, Knutson JC.
    Anticancer Res; 2004; 24(5A):2905-12. PubMed ID: 15517895
    [Abstract] [Full Text] [Related]

  • 22. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang GY.
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [Abstract] [Full Text] [Related]

  • 23. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.
    Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP.
    Cancer Res; 1999 Aug 15; 59(16):4023-9. PubMed ID: 10463602
    [Abstract] [Full Text] [Related]

  • 24. 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells.
    Swamy N, Persons KS, Chen TC, Ray R.
    J Cell Biochem; 2003 Aug 01; 89(5):909-16. PubMed ID: 12874825
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pamidronate and 1,24(S)-dihydroxyvitamin D2 synergistically inhibit the growth of myeloma, breast and prostate cancer cells.
    Wigington DP, Strugnell SA, Knutson JC.
    Anticancer Res; 2005 Aug 01; 25(3B):1909-17. PubMed ID: 16158925
    [Abstract] [Full Text] [Related]

  • 27. The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells.
    Quann EJ, Khwaja F, Zavitz KH, Djakiew D.
    Cancer Res; 2007 Apr 01; 67(7):3254-62. PubMed ID: 17409433
    [Abstract] [Full Text] [Related]

  • 28. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Apr 01; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ, Zheng J.
    Ai Zheng; 2006 Dec 01; 25(12):1470-6. PubMed ID: 17166369
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.
    Cho YL, Christensen C, Saunders DE, Lawrence WD, Deppe G, Malviya VK, Malone JM.
    Cancer Res; 1991 Jun 01; 51(11):2848-53. PubMed ID: 2032225
    [Abstract] [Full Text] [Related]

  • 33. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q, Titus MA, Fung KM, Lin HK.
    J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
    Moffatt KA, Johannes WU, Miller GJ.
    Clin Cancer Res; 1999 Mar 01; 5(3):695-703. PubMed ID: 10100724
    [Abstract] [Full Text] [Related]

  • 36. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [Abstract] [Full Text] [Related]

  • 37. Efficient dual treatment of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,25-dihydroxyvitamin D3.
    Belochitski O, Ariad S, Shany S, Fridman V, Gavrilov V.
    In Vivo; 2007 Jun 01; 21(2):371-6. PubMed ID: 17436590
    [Abstract] [Full Text] [Related]

  • 38. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
    Dial EJ, Doyen JR, Lichtenberger LM.
    Cancer Chemother Pharmacol; 2006 Feb 01; 57(3):295-300. PubMed ID: 16032431
    [Abstract] [Full Text] [Related]

  • 39. Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
    Clyburn RD, Reid P, Evans CA, Lefley DV, Holen I.
    Cancer Chemother Pharmacol; 2010 Apr 01; 65(5):969-78. PubMed ID: 19730863
    [Abstract] [Full Text] [Related]

  • 40. [Inhibition of vascular smooth muscle cell proliferation by non-steroidal anti-inflammatory drugs].
    Wang YQ, Brooks G, Harper J, Li YQ, Zhu CB, Yuan WZ, Wu XS.
    Shi Yan Sheng Wu Xue Bao; 2003 Apr 01; 36(2):85-90. PubMed ID: 12858504
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.